December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Elisa Agostinetto: Our review on emerging treatments for HER2+ breast cancer
May 20, 2024, 11:18

Elisa Agostinetto: Our review on emerging treatments for HER2+ breast cancer

Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on LinkedIn:

“Now out in Cell Reports Medicine, our review on emerging treatments for HER2+ breast cancer.

We discuss how survival improvements in this disease set a high bar for new drug development and the need to explore new ways to overcome resistance mechanisms.”

Elisa Agostinetto

Additional information.
Source: Elisa Agostinetto/LinkedIn